Western blotting analysis also showed that the combination treatment of apigenin and ABT-263 induced greater cleavage of caspase 3 and PARP than the drugs did alone, further demonstrating a synergistic interaction between ABT-263 and apigenin in EGFRm tumor cells (Fig. 2f). The gene discussed is CASP3; the disease is neoplasm.